PAIN
Volume 149, Issue 3 , Pages 415-416 , June 2010

PAIN’s policy on the spinal administration of drugs

Received 9 February 2010 ,Accepted 17 February 2010.

References 

  1. Eisenach JC, Shafer SL, Yaksh T. The need for a journal policy on intrathecal, epidural, and perineural administration of non-approved drugs. Pain. 2010;149:417–419
  2. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343:1514–1519
  3. Kotani N, Matsuki A. Author reply. N Engl J Med. 2001;344:1021–1022
  4. Lewis G. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1020;[author reply 1021–1022]
  5. Munts AG, van der Plas AA, Voormolen JH, Marinus J, Teepe-Twiss IM, Onkenhout W, et al. Intrathecal glycine for pain and dystonia in complex regional pain syndrome. Pain. 2009;146:199–204
  6. Nelson DA, Landau WM. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1019
  7. Niebergall H, Priebe HJ. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1020
  8. Srinivasan B. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1021
  9. Watson CPN. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1022
  10. Zetlaoui PJ, Cosserat J. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 2001;344:1020–1021[author reply 1021–1022]

PII: S0304-3959(10)00119-3

doi: 10.1016/j.pain.2010.02.027

PAIN
Volume 149, Issue 3 , Pages 415-416 , June 2010

Article Tools